INTERCEPT
INTERCEPT
Description
At INTERCEPT, we are transforming the landscape of Crohn’s disease research by shifting from reactive symptom management to proactive early detection and prevention. Our groundbreaking approach leverages biomarkers - measurable substances found in body fluids that can signal the presence of the earliest stages of the disease before it clinically manifests - to identify individuals at risk before symptoms develop, enabling timely and effective interventions that could stop the disease before it starts.
General Design
- Start/End data collection
- 2025 (ongoing)
Population
- Countries
- United States of America (the), United Kingdom of Great Britain and Northern Ireland (the), Switzerland, Sweden, Spain, Portugal, Poland, Norway, Netherlands (the), Korea (the Republic of), Italy, Germany, France, Denmark, Belgium, Austria
Organisations
Lead organisations
- Amsterdam University Medical CentersNetherlands (the)https://www.amsterdamumc.org
Data originator, Researcher
Additional organisations
- National Medical Institute of the Ministry of Interior and Administration (PIM MSWiA)Polandhttp://pimmswia.gov.pl
Data originator, Researcher
- Richard Vesely
Other
- University Medical Center Groningen (UMCG)Netherlands (the)https://www.umcg.nl
Data holder, Data provider, Researcher, Data access provider, Other
- Ludger (United Kingdom)United Kingdom of Great Britain and Northern Ireland (the)https://www.ludger.com/
Researcher
- Icahn School of Medicine at Mount Sinai (ISMMS)United States of America (the)https://icahn.mssm.edu
Researcher
- Hospital da Luz
GLSMED Learning Health SAPortugalhttp://www.hospitaldaluz.pt/lisboa/en/Data provider
- University of Oxford
The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom of Great Britain and Northern Ireland (the)https://www.ox.ac.ukResearcher
- International Federation of Crohn's & Ulcerative Colitis Associations (IFCCA)Belgiumhttps://www.ifcca-ibd.org
Other
- Agostino Gemelli University Polyclinic
Gemelli Digital Medicine & HealthItalyhttps://www.policlinicogemelli.it/Researcher
- Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)Spainhttps://geteccu.org/
Other
Funding & Acknowledgements
- Funding
- This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101194780. The JU receives support from the European Union’s Horizon Europe Research and Innovation Programme and COCIR, EFPIA, Europa Bío, MedTech Europe, Vaccines Europe, and Ludger Ltd, Celltrion Inc. and Prometheus Laboratories Inc. Co-Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.